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Abstract
Background: Toxoplasma gondii is an obligate intracellular parasite of the phylum Apicomplexa and a major
pathogen of animals and immunocompromised humans, in whom it causes encephalitis. Understanding the
mechanism of tachyzoite invasion is important for the discovery of new drug targets and may serve as a model for
the study of other apicomplexan parasites. We previously showed that Plasmodium falciparum expresses a homolog
of human calcium calmodulin-dependent protein kinase (CaMK) that is important for host cell invasion. In this
study, to identify novel targets for the treatment of Toxoplasma gondii infection (another apicomplexan parasite),
we sought to identify a CaMK-like protein in the T. gondii genome and to characterize its role in the life-cycle of
this parasite.
Methods: An in vitro kinase assay was performed to assess the phosphorylation activities of a novel CaMK-like
protein in T. gondii by using purified proteins with various concentrations of calcium, calmodulin antagonists, or T.
gondii glideosome proteins. Indirect immunofluorescence microscopy was performed to detect the localization of
this protein kinase by using the antibodies against this protein and organellar maker proteins of T. gondii.
Results: We identified a novel CaMK homolog in T. gondii, T. gondii CaMK-related kinase (TgCaMKrk), which exhibits
calmodulin-independent autophosphorylation and substrate phosphorylation activity. However, calmodulin
antagonists had no effect on its kinase activity. In T. gondii-infected cells, TgCaMKrk localized to the apical ends of
extracellular and intracellular tachyzoites. TgCaMKrk phosphorylated TgGAP45 for phosphorylation in vitro.
Conclusions: Our data improve our understanding of T. gondii motility and infection, the interaction between
parasite protein kinases and glideosomes, and drug targets for protozoan diseases.
Keywords: Calcium calmodulin-dependent protein kinase homolog, GAP45, Phosphorylation, T. gondii CaMK-related
kinase, Toxoplasma gondii
Background
Toxoplasma gondii is an obligate intracellular parasite of
the phylum Apicomplexa and a major pathogen of ani-
mals and immunocompromised humans, in whom it
causes encephalitis [1, 2]. In humans, ingested T. gondii
cysts release asexually reproducing bradyzoites that
differentiate into tachyzoites, which propagate the infec-
tion by spreading through the body via the blood and
lymphatic systems. While the immune system can nor-
mally clear a T. gondii infection, immunocompromised
individuals, such as those infected with human immuno-
deficiency virus, have trouble doing so and can develop
severe toxoplasmosis [3]. Although drugs to treat toxo-
plasmosis are available, they are poorly tolerated, have
severe side effects, and are ineffective against chronic
Toxoplasma infections [4, 5]. Therefore, new drugs are
urgently needed. To discover new drug targets, we must
first understand the mechanism of tachyzoite invasion.
* Correspondence: kkato@obihiro.ac.jp
1National Research Center for Protozoan Diseases, Obihiro University of
Agriculture and Veterinary Medicine, Inada-cho, Obihiro, Hokkaido 080-8555,
Japan
2Department of Veterinary Microbiology, Graduate School of Agricultural and
Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo
113-8657, Japan
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Kato et al. Parasites & Vectors  (2016) 9:405 
DOI 10.1186/s13071-016-1676-1
Such knowledge may also benefit the study of other
apicomplexan parasites.
Our laboratory and others have demonstrated the
importance of parasitic kinases for T. gondii [6–10];
however, no kinase function has been found to be of
critical importance in the primary host, felines. For
tachyzoite invasion of a host cell, many kinases are
called to action, including T. gondii calcium-dependent
protein kinase 1 (TgCDPK1) [7, 11–13], T. gondii cyclic
GMP-dependent protein kinase [14], and TgCDPK1_2
[8]. TgCDPK1 also participates in the egress of tachy-
zoites from infected cells [12]. Additional T. gondii pro-
tein kinases are involved in host manipulation, cell cycle
regulation, and functions required for growth, stress re-
sponses, and the transition from tachyzoite to bradyzoite
[15]. Thus, given their level of involvement in many
aspects of the parasitic life-cycle, the kinases encoded by
the parasite genome are obvious potential drug targets.
The motility of T. gondii tachyzoites is activated by an
increase in the cytosolic Ca2+ concentration [16], which
occurs as the parasites egress from the host cells [17,
18]. This increase in Ca2+ concentration causes the para-
sites to secrete adhesion molecules from its microneme
[19]. An actin/myosin-based motor complex, the glideo-
some [20], powers parasite motility and is a conserved
feature of apicomplexans [21]. The glideosome of T. gon-
dii is a macromolecular complex that includes myosin
A, myosin light chain (TgMLC1), T. gondii glideosome-
associated protein 50 (TgGAP50), TgGAP45, aldolase 1,
and actin 1 (TgACT1) [20]. TgGAP40, TgGAP70, and
TgGAP80 are also glideosome components [22, 23]. The
glideosome, which is located between the parasite’s
plasma membrane and its inner membrane complex,
mediates motility, migration, host cell invasion, and
egress. In T. gondii and another apicomplexan family
member, Plasmodium falciparum, the phosphorylation
of glideosome components within the tachyzoite, or
merozoite in the case of P. falciparum, occurs during in-
vasion and helps control gliding, invasion, and egress. In
T. gondii, the phosphorylation of Ser163 and Ser167 in
TgGAP45 marks the final step in glideosome assembly
[24]. Structural modeling studies have shown that Ser163
and Ser167 are Ca2+-insensitive and that Ser184/5 and
Thr189 are Ca2+-sensitive phosphorylation sites on
TgGAP45 [25]. PfCDPK1 localizes to the periphery of
merozoites where it acts on myosin A tail domain-
interacting protein (MTIP) and PfGAP45 at the inner
membrane complex. PfCDPK1 can also phosphorylate
MTIP and PfGAP45 in vitro [26].
We previously characterized P. falciparum protein kin-
ase 2 (PfPK2), which is a unique homolog of human Ca2
+ calmodulin-dependent protein kinase (CaMK) [27].
PfPK2 phosphorylates its substrate in a Ca2+- and
calmodulin-dependent manner. In the present study, we
identified a homolog of PfPK2 in T. gondii, T. gondii
CaMK-related kinase (TgCaMKrk) (ToxoDB ID:
TGME49_315190; GenBank accession number:
AB699221), which exhibits autophosphorylation and his-
tone phosphorylation activity. However, calmodulin an-
tagonists had no effect on its kinase activity. We further
show that TgCaMKrk is expressed in T. gondii-infected
cells and localizes to the apical ends of extracellular and
intracellular tachyzoites, and that it specifically targets
TgGAP45 for phosphorylation in vitro.
Methods
Target cells and parasites
Tachyzoites of T. gondii RH strain were used in this
study. The parasite was maintained in monolayers of
Vero cells cultured in Dulbecco’s modified Eagle’s
medium (DMEM) containing 7.5 % fetal calf serum
(FCS), 2 mM L-glutamine, 20 mM HEPES (pH 7.5),
streptomycin, and penicillin.
Sequence analysis and identification of the TgCaMKrk
open reading frame (ORF)
T. gondii RH strain mRNA was isolated from infected
Vero cells by using TRIZOL (Invitrogen, Carlsbad, CA,
USA) according to the manufacturer’s instructions. A
cDNA library of T. gondii RH strain was amplified by
RT-PCR using parasite mRNA as the template and
SuperScrip III Reverse Transcriptase with oligo dT pri-
mer (Invitrogen, Carlsbad, CA, USA). The TgCaMKrk
ORF was identified by sequence analysis of the T. gondii
cDNA library by using an Applied Biosystems 3130 Gen-
etic Analyzer.
Plasmids
The TgCaMKrk gene encoding the predicted kinase
domain (amino acids [a.a.] 1–866) was amplified by RT-
PCR using parasite mRNA as the template and the follow-
ing primers: forward, 5'-GCG CCT CGA GGG AGA
AGT TTT TGG CGC TTT-3' (XhoI digestion site is
underlined), and reverse, 5'-GCA CTA GTC TAC ACG
TGA CGA AGT GGA A-3' (SpeI digestion site is under-
lined). The product was digested with XhoI/SpeI and cloned
into pEU (CellFree Sciences, Yokohama, Japan) to generate a
GST fusion protein. The resultant plasmid was designated
pEU-GST-TgCaMKrk (Fig. 1b). To generate pEU-GST-
TgCaMKrkKA, Lys218 of TgCaMKrk was replaced with Ala
by using a QuikChange Site-Directed Mutagenesis Kit
(Stratagene, Santa Clara, CA, USA) with the oligonucleotide
5'-GAG AAG GTC GTT GTC GCG GCC ATC AAC
AAA AAG-3' and its complement, according to the manu-
facturer’s instructions. The complete ORFs of TgGAP45,
TgACT1, TgMLC1, and TgGAP50 were amplified
from parasite mRNA by RT-PCR using the primers
listed in Table 1. The amplified fragments were
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digested with the restriction enzymes indicated in
Table 1 and cloned in-frame into pMal-c (New
England BioLabs, Beverly, MA, USA) with maltose-
binding protein (MBP) to generate pMal-TgGAP45,
pMal-TgACT1, pMal-TgMLC1, and pMal-TgGAP50, re-
spectively. Simultaneously, a TgGAP45 mutant plasmid that
lacked most of the coiled-coil domain (a.a. 27–136) [24],
was also generated (refer to Fig. 6a).
Wheat germ cell-free protein synthesis system
Protein expression using a wheat germ cell-free protein
synthesis system (CellFree Sciences) was achieved as de-
scribed previously [27, 28]. Briefly, at the transcription
step, 2 μg of pEU-GST-GFP or pEU-GST-TgCaMKrk
was mixed with 18 μl of transcription mixture (tran-
scription buffer with 2.5 mM NTP mix, 1 U/μl RNase
inhibitor, and 1 U/μl SP6 RNA polymerase; CellFree
Sciences) and incubated at 37 °C for 6 h. Each mRNA
generated was then mixed with 10.8 μl of WEPRO1240G
(CellFree Sciences) and 40 ng/μl creatine kinase (Roche,
Mannheim, Germany), transferred to the bottom of the
SUB-AMIX solution (CellFree Sciences) to form a bilayer,
and incubated at 16 °C for 20 h. To determine whether
the resultant protein was bound to Ca2+ or calmodulin
upon translation, DMSO (negative control), the calmodu-
lin antagonist W-7 (0.66 mM; BIOMAL, Plymouth
Fig. 1 Diagrams of the putative amino acid sequences of PfPK2 and TgCaMKrk, and of the expression plasmids used in this study. a The amino
acid sequences of PfPK2 and TgCaMKrk are shown; the catalytic and regulatory domains, including the autoinhibitory and calmodulin-binding
domains [27], are shaded. TgCaMKrk has no regulatory domain. The arrow denotes the conserved catalytic lysine. b The plasmids (pEU-GST-
TgCaMKrk and pEU-GST-TgCaMKrkKA) used for the expression of GST-TgCaMKrk and GST-TgCaMKrkKA, respectively, in the wheat germ cell-free
protein synthesis system are shown. The SP6 promoter (SP6), translational enhancer (E01), GST, and tobacco etch virus protease recognition site
are indicated [36]
Table 1 The list of primers used to generate the expression vectors
Expression plasmid Direction Sequence
pMal-TgGAP45 Forward a 5′-GCGAATTCGGAAACGCGTGCAAGAAGAA-3′
Reverse b 5′-GCCTGCAGTCAGTTCAACAAGGGTGCAT-3′
pMal-TgACT1 Forward a 5′-GCGAATTCGCGGATGAAGAAGTGCAAGC-3′
Reverse c 5′-GCTCTAGATTAGAAGCACTTGCGGTGGA-3′
pMal-TgMLC1 Forward a 5′-GGAATTCGCGAGCAAGACCACGTCTG-3′
Reverse c 5′-GCTCTAGACTAGAACGCCGGCTGAACAG-3′
pMal-TgGAP50 Forward d 5′-GGGGTACCGGCAGGCGCCCCCGTCGCG-3′
Reverse c 5′-GCTCTAGATTATTTCATGTAGCGAGAG-3′
a EcoRI site is underlined. b PstI site is underlined. c XbaI site is underlined. d KpnI site is underlined
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Meeting, PA, USA), or calmidazolium (0.05 mM; Sigma-
Aldrich, St. Louis, MO, USA) was added to the SUB-
AMIX solution.
Purification of recombinant proteins
Wheat germ extracts were mixed with 10 μl of a 50 %
slurry of glutathione-Sepharose beads (GE Healthcare,
Little Chalfont, Buckinghamshire, UK) for 16 h. The
beads were then washed three times with phosphate-
buffered saline (PBS). Purified protein captured on the
beads was separated by 10 % sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) after
boiling and was then either silver stained or immuno-
blotted with anti-α-GST antibodies (Sigma-Aldrich).
Purification of the recombinant proteins expressed in
Escherichia coli XL-1 blue transformed with plasmids
harboring MBP-TgGAP45, MBP-TgACT1, MBP-
TgMLC1, or MBP-TgGAP50 was performed as described
elsewhere [29].
In vitro kinase assay
Purified GST-GFP, GST-TgCaMKrk, or GST-
TgCaMKrkKA captured on glutathione-Sepharose
beads was rinsed twice with washing buffer (50 mM
Tris-HCl, pH 9.0, and 2 mM DTT). Kinase assay
reactions were performed with the purified GST fu-
sion proteins at 37 °C for 30 min in 50 μl of kinase
buffer (50 mM Tris-HCl, pH 8.0, 200 mM NaCl,
50 mM MgCl2, 0.1 % Nonidet P-40, 1 mM DTT,
5 μM ATP, and 10 μM CaCl2) containing 5 μCi of [γ-
32P]ATP. After incubation, the samples were washed
three times with TNE buffer (20 mM Tris-HCl,
pH 8.0, 100 mM NaCl, and 1 mM EDTA), and the
phosphorylated proteins were separated by 10 % SDS-
PAGE. The gels were stained with Coomassie Brilliant
Blue (CBB), dried, and exposed to X-ray film [27, 28].
Phosphatase treatment
After in vitro kinase assays, GST fusion proteins cap-
tured on glutathione-Sepharose beads were subjected to
phosphatase treatment, as described elsewhere [27, 28].
Antibodies
Rabbit anti-GRA6 polyclonal antibodies were kindly sent
to us by Dr. L.D. Sibley (Washington University School
of Medicine, St. Louis, MO, USA); rabbit anti-M2AP
(microneme protein 2-associated protein) polyclonal
antibodies were kindly provided by Dr. V. Carruthers
(John Hopkins University, Baltimore, MD, USA); rabbit
anti-ROP1 polyclonal antibodies were a gift from Dr. J.
Dubremetz (University of Montpellier, Montpellier,
France); and rabbit anti-TgGAP45 polyclonal antibodies
were a gift from Dr. D. Soldati (University of Geneva,
Switzerland).
Production of anti-TgCaMKrk antibodies
Mouse antiserum against TgCaMKrk was prepared by
immunizing BALB/c mice with purified GST-TgCaMKrk
expressed in a wheat germ cell-free system, purified on
glutathione-Sepharose beads, extensively washed with
buffer C, and eluted with elution buffer (10 mM gluta-
thione and 500 mM Tris-HCl, pH 8.0). For the first
immunization, a mixture of the eluted supernatants and
Freund’s complete adjuvant (Rockland, Gilbertsville, PA,
USA) was injected intraperitoneally into the mice. After
2 weeks, a mixture of the eluted supernatants and
Freund’s incomplete adjuvant (Rockland) was injected
three times, at 2-week intervals. One week after the final
injection, mouse antiserum against TgCaMKrk was
collected.
Immunoblotting and IFA
T. gondii RH strain was propagated and lysed by passing
the cells though a #27 syringe and was filtered by using
a 5-μm filter. The lysate was subjected to immunoblot-
ting as described elsewhere [30]. For indirect immuno-
fluorescence microscopy (IFA), purified extracellular
tachyzoites were fixed on a 14-well slide with 40 % for-
maldehyde and were permeabilized with 0.1 % Triton X-
100. The slide was incubated with antibodies against
TgCaMKrk and GRA6, TgGAP45, ROP-1, or M2AP, re-
spectively, for 60 min at 37 °C and then rinsed three
times with PBS. After incubation with AlexaFluor 488-
conjugated goat anti-mouse IgG (H + L) and AlexaFluor
546-conjugated goat anti-rabbit IgG (H + L) (Invitrogen)
for 60 min at room temperature, the slide was rinsed
three times with PBS. Intracellular tachyzoites were pre-
pared by infecting Vero cells cultured in an eight-well
chamber slide for 48 h; the slide was then fixed and
stained as described above.
Results
Identification of TgCaMKrk
We previously characterized PfPK2, a unique CaMK
encoded by the P. falciparum genome [27]. Calmodulin
antagonists inhibited PfPK2 kinase activity in vitro and
markedly decreased ring-stage parasitemia in invasion
assays [27]. CaMK plays important roles in Ca2+ signal-
ing during various cellular events, including carbohy-
drate metabolism, transcription, spermatogenesis,
transcription, neuronal memory, and mitochondrial bio-
genesis [31]. Therefore, we speculated that such a gene
likely exists in another apicomplexan parasite, T. gondii.
In this study, we sequenced and identified an ORF
(9,591 bp) of a novel T. gondii gene that included a se-
quence homologous to the catalytic domain of PfPK2.
These sequence analysis data were consistent with tran-
scriptional data from the RNA-seq of T. gondii ME49
strain performed by Drs. J. Yamagishi and X. Xuan
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(Obihiro University of Agriculture and Veterinary Medi-
cine; personal communication). The putative catalytic
domain of TgCaMKrk shares 57 % identity and 88 %
similarity with that of PfPK2; however, it has no homolo-
gous regulatory (autoinhibitory and calmodulin-binding)
domain and a long nonconserved region (Fig. 1a). We
named this gene T. gondii CaMK-related kinase
(TgCaMKrk) (GenBank accession number: AB699221).
Purification of the TgCaMKrk kinase domain by using a
wheat germ cell-free protein synthesis system
Our first objective was to purify the TgCaMKrk gene
product. However, the putative protein (3,197 amino
acids) was too large to be expressed in vitro. Therefore,
we expressed and purified the TgCaMKrk kinase domain
(N-terminal 866 amino acids), which includes the cata-
lytic domain, as a glutathione S-transferase (GST) fusion
protein by using a wheat germ cell-free protein synthesis
system (Fig. 1b). The kinase domain was selected be-
cause no other conserved domains were found during
our BLAST analysis of the TgCaMKrk putative amino
acids. The purified protein was then separated by de-
naturing gel electrophoresis and either silver stained
(Fig. 2a) or immunoblotted with anti-GST antibodies
(Fig. 2b). The purified protein products, GST-GFP, GST-
TgCaMKrk, and GST-TgCaMKrkKA, each contained
one major band (Mr values of 54,000, 121,000 and
121,000, respectively) and reacted with antiserum con-
taining anti-GST antibodies (Fig. 2b).
Protein kinase activity of TgCaMKrk
Many protein kinases exhibit autophosphorylation activ-
ity [32]. To determine whether TgCaMKrk has such ac-
tivity, we tested the purified protein in a kinase assay.
Purified fusion proteins were incubated in kinase buffer
containing [γ-32P]ATP, separated electrophoretically, and
stained with CBB (Fig. 3a and b). Purified GST-GFP
fusion protein, which was incubated in kinase buffer and
electrophoretically separated, did not contain any labeled
bands (Fig. 3a and b, Lanes 1). However, in the
autoradiographic image of purified TgCaMKrk, a protein
band with an apparent Mr of 121000 was labeled (Fig. 3b,
Lane2). The electrophoretic mobility of labeled
TgCaMKrk was the same as that of purified TgCaMKrk
stained with CBB (Fig. 3a and b). To confirm that the
[γ-32P]ATP labeling of TgCaMKrk was due to autophos-
phorylation, labeled TgCaMKrk was boiled (to inactivate
its kinase activity) and incubated with 5 U of alkaline
phosphatase at 37 °C for 30 min. No band corresponding
to labeled TgCaMKrk was detected after this phosphat-
ase treatment, indicating that TgCaMKrk was indeed
labeled with [γ-32P]ATP by phosphorylation (Fig. 3c and
Fig. 2 Expression and purification of GST-GFP, GST-TgCaMKrk, and GST-TgCaMKrkKA. Proteins were expressed by using a wheat germ cell-free
protein synthesis system. Total wheat germ extracts were subjected to affinity chromatography using glutathione-Sepharose beads. The purified
proteins were separated on denaturing gels and then (a) silver stained or (b) transferred to a nitrocellulose sheet and probed with anti-GST anti-
bodies. Lanes 1 and 2, GST-GFP; Lanes 3 and 4, GST-TgCaMKrk; Lanes 5 and 6, GST-TgCaMKrkKA. Lanes 1, 3, and 5, total wheat germ extracts;
Lanes 2, 4, and 6, purified proteins. Molecular masses (kDa) are shown on the left
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d). Importantly, the total TgCaMKrk protein levels were
similar before and after boiling. Thus, TgCaMKrk pos-
sesses protein kinase activity and is able to phosphoryl-
ate itself.
It is possible that the kinase activity we detected in
these experiments was caused by a contaminating ki-
nase(s) that physically associates with GST-TgCaMKrk,
or that it was non-specifically selected for by the
glutathione-Sepharose beads. To exclude these possibil-
ities, we constructed a mutant that lacked intrinsic
kinase activity but retained its overall structure. We used
site-directed mutagenesis to replace Lys218 of TgCaMKrk
with an Ala residue to generate the GST fusion protein
GST-TgCaMKrkKA (see Fig. 1b). Lys218 was chosen be-
cause it is conserved in subdomain II of known protein
kinases and is required for kinase activity [33], and
because mutation of the corresponding lysine in PfPK2
resulted in a loss of kinase activity [27]. The autophos-
phorylation activity of GST-TgCaMKrkKA was tested as
before using purified protein and [γ-32P]ATP. The wild-
type fusion protein was labeled by autophosphorylation
(Fig. 3b, Lane 2), whereas the mutant was not (Fig. 3b,
Lane 3). These results indicate that the substitution of
Lys218 abolished the kinase activity of TgCaMKrk and
that contaminating kinases were not a factor in our kin-
ase assay.
Neither Ca2+ nor calmodulin are required for the protein
kinase activity of TgCaMKrk
To determine whether the kinase activity of TgCaMKrk
is Ca2+ and/or calmodulin dependent, as was shown for
PfPK2 [27], we performed two series of experiments
(Fig. 4a). First, in vitro kinase assays were performed in
the presence of EGTA or 0–10 μM Ca2+. The kinase
activity of TgCaMKrk was the same, regardless of the
presence of Ca2+. Next, we assessed the effect of Ca2+
and calmodulin on the phosphorylation activity of
TgCaMKrk. We found that TgCaMKrk activity was not
affected by the presence of 10 μM Ca2+ or 10 μM
calmodulin, while the autophosphorylation of PfPK2
depended on the calcium concentration.
We also tested the effect of calmodulin antagonists on
the phosphorylation activity of TgCaMKrk, because we
had previously demonstrated their inhibition of PfPK2
activity in vitro and of erythrocyte invasion by P. falcip-
arum [27]. The translation mixture (i.e. WEPRO1240G)
used in the wheat germ cell-free system contained wheat
calmodulin, so we eliminated the wheat calmodulin at
the translation step by incubating the translation mix-
ture with the calmodulin antagonist W-7 or calmidazo-
lium. After translation and purification, TgCaMKrk
activity was assessed by scintillation counting. Both
autophosphorylation and histone phosphorylation were
Fig. 3 In vitro kinase assays of purified GST-GFP, GST-TgCaMKrk, and GST-TgCaMKrkKA. a Purified GST-GFP (Lane 1), GST-TgCaMKrk (Lane
2), or GST-TgCaMKrkKA (Lane 3) was incubated in kinase buffer containing [γ-32P]ATP, separated on a denaturing gel, and stained with
CBB. b Autoradiograph of the gel shown in a. c Purified GST-TgCaMKrk incubated in kinase buffer containing [γ-32P]ATP (Lane 1) and the labeled
protein treated with λ-protein phosphatase (Lane 2) were separated on a denaturing gel and then stained with CBB. d Autoradiograph of the gel
shown in c. Molecular masses (kDa) are indicated on the left
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slightly reduced after the addition of W-7 (Fig. 4b
and c), while the activity of autophosphorylation of
PfPK2 was greatly reduced after the addition of W-7.
Thus, neither Ca2+ nor calmodulin is required for the
kinase activity of TgCaMKrk. These results are con-
sistent with the fact that the putative amino acid
sequence of TgCaMKrk has a conserved catalytic do-
main but lacks the regulatory domain, which com-
prises the autoinhibitory and calmodulin-binding
domains in CaMK-like proteins (Fig. 1a) [33].
TgCaMKrk is expressed at the periphery of T. gondii
tachyzoites
To investigate the localization of TgCaMKrk, lysates of
T. gondii tachyzoites were immunoblotted with anti-
bodies raised against GST-TgCaMKrk in mice (Fig. 5). A
single band was detected at approximately 340 kDa,
which corresponds to the predicted molecular weight of
TgCaMKrk (Fig. 5a, Lane 4). No band was detected in
an uninfected Vero cell lysate (Fig. 5a, Lanes 1 and 2).
PfPK2 is expressed in the membrane of the parasite
[34]. Our previous IFA data showed that PfPK2 is
produced by merozoites during erythrocyte invasion
[27]. To determine the localization of the TgCaMKrk
protein in T. gondii, rabbit anti-GRA6, -GAP45, -ROP1
and -M2AP antibodies were employed to show the dense
granules, glideosome, rhoptry, and apical ends. As
shown in Fig 5b, in the released tachyzoite, the
TgCaMKrk signal did not completely co-localize with
any of the markers we used, but it was located more to-
ward the apical end of the M2AP signal and closest to
the GAP45 signal (Fig. 5b, 2nd panel). In the growing
tachyzoites in the infected cells, the TgCaMKrk signal
localized to the apical ends and again did not completely
co-localize with any of the marker signals (Fig. 5b, 5th–
8th panels). Pre-immune mouse serum did not stain any
parasites (data not shown). The TgCaMKrk signal at the
more apical end of M2AP suggests an apical end loca-
tion for TgCaMKrk; however, further study is required
to determine the precise localization of this protein.
TgCaMKrk specifically phosphorylates the glideosome
protein TgGAP45 in vitro
T. gondii and P. falciparum protein kinases phosphoryl-
ate glideosome component proteins, including GAP45
and MTIP [24, 26]. Because mass spectroscopy identified
residues Ser163 and Ser167 of TgGAP45 as phosphory-
lated residues [24], we used a deletion mutant of
TgGAP45 that contain the globular domain with the
predicted kinase-target residues Ser163 and Ser167
(Fig. 6a). As we obtained the data that TgCaMKrk signal
is localized at the apical end, the interaction between
TgCaMKrk and glideosome components should be ana-
lyzed. We selected glideosome components, TgACT1,
TgMLC1, and TgGAP50 including TgGAP45 [20] as
subjects of interest. To determine which glideosome
component TgCaMKrk phosphorylates, we performed in
vitro kinase assays using a TgGAP45 deletion mutant,
TgACT1, TgMLC1, TgGAP50, and LacZ as substrates
(Fig. 6b and c). Of the tested proteins, only TgGAP45
was phosphorylated by TgCaMKrk in vitro.
Discussion
This is the first report to describe the identification and
characterization of a CaMK-like protein in T. gondii,
TgCaMKrk. GST-TgCaMKrk containing the kinase do-
main was successfully expressed and purified by using a
wheat germ cell-free protein synthesis system.
TgCaMKrk was shown to have both autophosphoryl-
ation and substrate phosphorylation activity, as well as a
conserved catalytic lysine (Lys218). The catalytic domain
of TgCaMKrk shares 88 % similarity with that of PfPK2;
however, TgCaMKrk has no regulatory domain. The
regulatory domain of PfPK2 consists of autoinhibitory
and calmodulin-binding domains. The lack of such a do-
main in TgCaMKrk is reflected by the fact that
Fig. 4 Characterization of the kinase activity of TgCaMKrk. a In vitro
kinase assays were performed using purified GST-TgCaMKrk and
histone IIAS in the presence of EGTA or 0–10 μM Ca2+, or 10 μM
calmodulin and 10 μM Ca2+. The autophosphorylation of TgCaMKrk
was measured by scintillation counting. Effect of calmodulin
antagonists on the (b) autophosphorylation and (c) histone IIAS
phosphorylation activity of TgCaMKrk in the presence of DMSO or
the calmodulin antagonists W-7 and calmidazolium (calmidz.) in a
wheat germ cell-free system. The autophosphorylation and histone
phosphorylation activity of TgCaMKrk were measured by scintillation
counting. Representative data from three independent experiments
are shown
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calmodulin antagonists (W-7 and calmidazolium) did
not inhibit TgCaMKrk autophosphorylation or the his-
tone phosphorylation activity of TgCaMKrk. Some regu-
lation of TgCaMKrk must occur, however, because
continuous phosphorylation by this protein would pre-
sumably affect the parasite’s life-cycle. A BLAST search
via ToxoDB (http://toxodb.org/toxo/) using the putative
amino acid sequence of TgCaMKrk did not reveal a do-
main homologous to the regulatory domain of PfPK2.
Therefore, it is likely that another parasite protein regu-
lates the kinase function of TgCaMKrk.
Our IFA data showed that TgCaMKrk localizes to the
apical ends of extracellular tachyzoites. The localization
patterns of TgCaMKrk in extracellular tachyzoites were
more posterior to those of GAP45. Antibodies against
TgGAP45 stained the inner membrane complex, but not
the plasma membrane [35]. Previous fractionation ana-
lysis of P. falciparum indicated that PfPK2 is also
expressed in the parasite’s inner membrane [34]. These
findings suggest that TgCaMKrk could be secreted as it
is associated with apical organelles, and it could have
activity against host proteins for pathogenesis, and
localize with a specific organelle in the inner membrane
complex in tachyzoites.
TgCaMKrk specifically phosphorylated TgGAP45 in
the glideosome in vitro. The residues of TgGAP45 phos-
phorylated by TgCaMKrk were most likely Ser163 and
Ser167. Mutation of these residues to Glu prevented as-
sociation of the MyoA-MLC1-GAP45 complex with
GAP50, but did not have any obvious effects on motility
or host cell invasion, suggesting that Ser163 and Ser167
phosphorylation controls the final step in assembly of
the myosin XIV motor complex [24].
TgGAP70 localized to the apical cap of extracellular
tachyzoites, whereas TgGAP45 localized to the periphery
[22]. When we examined the homology between
TgGAP45 and TgGAP70, we found that the similarity
was approximately 73 % (Genetyx). However, the critical
serine residues corresponding to Ser163 and Ser167 of
TgGAP45 are not conserved in TgGAP70. Further ana-
lysis of TgCaMKrk in extracellular tachyzoites is needed
to clarify its substrates.
T. gondii kinases play important and diverse roles in the
parasite’s life-cycle [15]. Inhibitor studies suggest that ki-
nases are crucial regulators of parasite invasion. Therefore,
such proteins represent good potential drug targets for
blocking parasite-specific activity. On the basis of the data
presented here, we suggest that TgCaMKrk should be
Fig. 5 Expression of TgCaMKrk in T. gondii-infected cells. a Immunoblotting was performed using lysates from T. gondii (Lanes 1 and 2) or Vero
cells (Lanes 3 and 4) and anti-TgCaMKrk mouse serum (Lanes 2 and 4) or pre-immune mouse serum (Lanes 1 and 3). The arrowhead indicates
expression of TgCaMKrk. Molecular masses (kDa) are indicated on the left. b Localization of TgCaMKrk in T. gondii. Mouse anti-TgCaMKrk antibody
was used as the primary antibody, and anti-GRA6, -GAP45, -ROP1 and -M2AP antibodies from rabbits were used as markers of parasite organelles.
Nuclei are stained with TO-PRO3. The four upper panels indicate the extracellular parasite; the four lower panels indicate the intracellular T. gondii.
Differential interference contrast (DIC) images and overlaid images are shown in the two right panels. Scale-bar: 5 μm
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explored as a drug target, because it localizes to the apical
ends of T. gondii tachyzoites and could be associated with
the glideosome. Future studies should focus on the regula-
tory mechanism for this protein kinase and its overall im-
pact on the life-cycle of T. gondii.
Conclusion
In this study, we identified TgCaMKrk, which exhibits
autophosphorylation and histone phosphorylation activ-
ity. TgCaMKrk is expressed in T. gondii-infected cells
and localizes to the apical ends of extracellular and
intracellular tachyzoites. TgCaMKrk phosphorylates
TgGAP45 in vitro. Our data further our understanding
of T. gondii motility and infection, the interaction be-
tween parasite protein kinases and glideosomes, and
drug targets for protozoan diseases.
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Fig. 6 In vitro kinase assay of T. gondii component proteins with TgCaMKrk. a A schematic diagram of the TgGAP45 domain structure and its deletion
mutant is shown. TgGAP45 consists of an N-terminal coiled-coil domain (shaded) and a C-terminal globular domain. The two phosphorylation sites,
Ser163 and Ser167 [24], are indicated by arrows. The TgGAP45 mutant has a deletion in its coiled-coil domain (a.a. 27–136). b MBP-GAP45 mutant
(predicted MW, 59 kDa; Lane 1), MBP-ACT1 (84 kDa; Lane 2), MBP-MLC1 (66 kDa; Lane 3), MBP-GAP50 (88 kDa; Lane 4), and MBP-LacZ (51 kDa; Lane 5)
were immobilized on amylose resin beads and subjected to in vitro kinase assays with TgCaMKrk. The proteins were then washed three times with
TNE buffer, separated on a denaturing gel, and stained with CBB. c An autoradiograph of the gel shown in A. Molecular masses (kDa) are indicated on
the left
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